<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    17133159
   </pmid>
   <datecreated>
    <year>
     2006
    </year>
    <month>
     11
    </month>
    <day>
     29
    </day>
   </datecreated>
   <datecompleted>
    <year>
     2007
    </year>
    <month>
     02
    </month>
    <day>
     08
    </day>
   </datecompleted>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0891-3668
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       25
      </volume>
      <issue>
       12
      </issue>
      <pubdate>
       <year>
        2006
       </year>
       <month>
        Dec
       </month>
      </pubdate>
     </journalissue>
     <title>
      The Pediatric infectious disease journal
     </title>
     <isoabbreviation>
      Pediatr. Infect. Dis. J.
     </isoabbreviation>
    </journal>
    <articletitle>
     Ciprofloxacin treatment in preterm neonates in Bangladesh: lack of effects on growth and development.
    </articletitle>
    <pagination>
     <medlinepgn>
      1137-41
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext label="BACKGROUND" nlmcategory="BACKGROUND">
      Quinolone-induced arthropathic toxicity in weight-bearing joints observed in juvenile animals during preclinical testing has largely restricted the routine use of ciprofloxacin in the pediatric age group. As histopathologic, radiologic and magnetic resonance imaging monitoring evidence has gathered supporting the safety of fluoroquinolones in children, many pediatricians have started to prescribe quinolones to some patients on a compassionate basis.
     </abstracttext>
     <abstracttext label="OBJECTIVE" nlmcategory="OBJECTIVE">
      The objective of this study was to ascertain the safety of ciprofloxacin in preterm neonates &lt;33 weeks gestational age treated at Dhaka Shishu (Children) Hospital in Bangladesh.
     </abstracttext>
     <abstracttext label="METHODS" nlmcategory="METHODS">
      Long-term follow up was done to monitor the growth and development of preterm infants who were administered intravenous ciprofloxacin in the neonatal period. Ciprofloxacin was used only as a life-saving therapy in cases of sepsis produced by bacterial agents resistant to other antibiotics. Another group of preterm neonates with septicemia who were not exposed to ciprofloxacin, but effectively treated with other antibiotics and followed up, were matched with cases for gender, gestational age and birth weight and included as a comparison group. Forty-eight patients in the ciprofloxacin group and 66 patients in the comparison group were followed up for a mean of 24.7 +/- 18.5 months and 21.6 +/- 18.8 months, respectively.
     </abstracttext>
     <abstracttext label="RESULTS" nlmcategory="RESULTS">
      No osteoarticular problems or joint deformities were observed in the ciprofloxacin group during treatment or follow up. No differences in growth and development between the groups were found.
     </abstracttext>
     <abstracttext label="CONCLUSIONS" nlmcategory="CONCLUSIONS">
      Ciprofloxacin is a safe therapeutic option for newborns with sepsis produced by multiply resistant organisms.
     </abstracttext>
    </abstract>
    <affiliation>
     Department of Neonatology, Child Development Centre, Child Development and Neurology Unit, Dhaka, Bangladesh.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Ahmed
      </lastname>
      <forename>
       A S M Nawshad Uddin
      </forename>
      <initials>
       AS
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Khan
      </lastname>
      <forename>
       Naila Z
      </forename>
      <initials>
       NZ
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Saha
      </lastname>
      <forename>
       Samir K
      </forename>
      <initials>
       SK
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Chowdhury
      </lastname>
      <forename>
       M A K Azad
      </forename>
      <initials>
       MA
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Muslima
      </lastname>
      <forename>
       Humaira
      </forename>
      <initials>
       H
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Law
      </lastname>
      <forename>
       Paul
      </forename>
      <initials>
       P
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Islam
      </lastname>
      <forename>
       Maksuda
      </forename>
      <initials>
       M
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Bhattacharya
      </lastname>
      <forename>
       Mallika
      </forename>
      <initials>
       M
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Darmstadt
      </lastname>
      <forename>
       Gary L
      </forename>
      <initials>
       GL
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Clinical Trial
     </publicationtype>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Research Support, Non-U.S. Gov't
     </publicationtype>
     <publicationtype>
      Research Support, U.S. Gov't, Non-P.H.S.
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     United States
    </country>
    <medlineta>
     Pediatr Infect Dis J
    </medlineta>
    <nlmuniqueid>
     8701858
    </nlmuniqueid>
    <issnlinking>
     0891-3668
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      85721-33-1
     </registrynumber>
     <nameofsubstance>
      Ciprofloxacin
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    IM
   </citationsubset>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N" type="Geographic">
      Bangladesh
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Child Development
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Ciprofloxacin
     </descriptorname>
     <qualifiername majortopicyn="Y">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Follow-Up Studies
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Infant
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Infant, Newborn
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Infant, Premature
     </descriptorname>
     <qualifiername majortopicyn="Y">
      growth &amp; development
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Infant, Premature, Diseases
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Injections, Intravenous
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Male
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Sepsis
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
    </meshheading>
   </meshheadinglist>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      2006
     </year>
     <month>
      11
     </month>
     <day>
      30
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2007
     </year>
     <month>
      2
     </month>
     <day>
      9
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      2006
     </year>
     <month>
      11
     </month>
     <day>
      30
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="doi">
     10.1097/01.inf.0000245105.99934.5f
    </articleid>
    <articleid idtype="pii">
     00006454-200612000-00008
    </articleid>
    <articleid idtype="pubmed">
     17133159
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

